LPM Platform Products

Scalable enzymes, born immobilized

Lattice Protein Materials (LPM), developed by Xtelligence, is a platform that takes high-value proteins and enzymes that have been difficult to express and produce, and carries them to practical scale while preserving activity.

Overview

We sell and license LPM-scaffolded enzymes

We work with partners to transform their enzymes into robust, scalable LPM-based catalysts, while also developing our own LPM-based enzyme products and multi-enzyme systems.

For Industry

Scaling enzyme processes to practical use

Supports cost optimization by using enzymes in continuous processes, taking advantage of immobilization and reusability.

Partnering with AI protein design

Providing the stability layer

Makes it possible to evaluate target proteins that were previously hard to express in hosts such as E. coli, while retaining activity.

Core Capabilities

Five ways LPM delivers value

  • 01

    Higher enzyme yield by mitigating cytotoxicity

  • 02

    Industrial stability – thermal and organic-solvent stability

  • 03

    Reusability – strong activity after 10× reuse

  • 04

    Cofactor regeneration – enabling new chemistry

  • 05

    Multi-enzyme cascade reactions

  • What’s your use case?

    Tell us about your target protein or enzyme.

    Contact us →

How It Works

The LPM platform workflow

We support you end to end, from receiving a target protein through to practical use.

  1. Selecting the target enzyme

    We hear about your target enzyme or protein and evaluate whether LPM is a fit.

  2. Proof of Concept

    Your protein is born immobilized within an LPM lattice and activity confirmed

  3. Optimization

    Your protein is born immobilized within an LPM lattice, and optimized to achieve commercial metrics

  4. Scale up

    Commercial production demonstrated, followed by supply agreement or licensing

Demonstrated products

Enzymes we have demonstrated

Published demonstrations from the Ueno Lab at Institute of Science Tokyo (Xtelligence CSO) — the academic foundation of LPM — together with targets now in development. We can evaluate your target enzyme with the same approach.

* PKC, formate dehydrogenase, and the CALB × ADH cascade are results from peer-reviewed papers published by the Ueno Lab at Institute of Science Tokyo (Xtelligence CSO). We evaluate individual target enzymes and proteins based on your requirements.

Where It’s Used

Initial applications

LPM is a platform technology not limited to a single industry. See the Applications page for details.

  • Pharmaceuticals & intermediates

    Efficient synthesis of APIs and intermediates via biocatalytic processes using highly active enzymes.

  • Flavor & Fragrance Ingredients

    Improving yields where conversion efficiency is critical, including fragrance synthesis and amino-acid production.

  • Industrial Biocatalysis

    Replacing parts of chemical processes with enzymatic reactions to reduce energy use.

Get in touch

We welcome technical discussions and collaboration inquiries about your target protein or enzyme.

Contact